Constellation Pharmaceuticals, Inc. – NASDAQ:CNST

Constellation Pharmaceuticals stock price today

$33.99

Constellation Pharmaceuticals stock price yearly change

-4.20%
year

Constellation Pharmaceuticals key metrics

Market Cap
 N/A
Enterprise value
 1.51B
P/E
 -11.53
EV/Sales
 N/A
EV/EBITDA
 -10.96
Price/Sales
 N/A
Price/Book
 4.30
PEG ratio
 0.24
EPS
 -3.04
Revenue
 N/A
EBITDA
 -138.24M
Income
 -140.98M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Constellation Pharmaceuticals stock price history

Constellation Pharmaceuticals stock forecast

Constellation Pharmaceuticals financial statements

Profit Margin

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Profit margin
Jun 2020 0 -29.75M
Sep 2020 0 -33.77M
Dec 2020 0 -37.38M
Mar 2021 0 -40.07M
CNST income statement history

Quarterly Earnings

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Earnings per share (EPS)
2020-10-29 -0.68 -0.71
2021-02-24 -0.76 -0.79
2021-05-10 -0.79 -0.84
CNST earnings history

Debt to Assets

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Debt to assets
Jun 2020 534798000 62.81M 11.75%
Sep 2020 505449000 62.67M 12.4%
Dec 2020 441854000 31.13M 7.05%
Mar 2021 402659000 25.34M 6.29%
CNST balance sheet history

Cash Flow

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Cash Flow
Jun 2020 -21.03M -172.54M 182.22M
Sep 2020 -30.81M -31.77M 467K
Dec 2020 -33.55M 114.16M -31.11M
Mar 2021 -39.73M -11.20M 1.23M
CNST cash flow history

Constellation Pharmaceuticals alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Constellation Pharmaceuticals
Employees

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Employee count
Aug 2023 154
Sep 2023 154
Oct 2023 154
Nov 2023 154
Dec 2023 154
Jan 2024 154
Feb 2024 154
Mar 2024 154
Apr 2024 154
May 2024 154
Jun 2024 154
Jul 2024 154

Constellation Pharmaceuticals other data

Constellation Pharmaceuticals
Insider Trading

Constellation Pharmaceuticals, Inc. (NASDAQ:CNST): Insider trades (number of shares)
Period Buy Sel
Mar 2020 41674 617
Apr 2020 0 9618
May 2020 0 107238
Jun 2020 0 1178
Dec 2020 0 9740
Jan 2021 0 34406
Feb 2021 0 21780
Transaction Date Insider Security Shares Price per share Total value Source
Option
GOLDSMITH MARK A director Common Stock 14,987 N/A N/A
Option
GOLDSMITH MARK A director Stock Option (right to buy) 14,987 N/A N/A
Option
REEVE EMMA officer: Chief Financial Officer
 Common Stock 6,260 $37.6 $235,376
Sale
REEVE EMMA officer: Chief Financial Officer
 Common Stock 6,260 $37.6 $235,376
Option
REEVE EMMA officer: Chief Financial Officer
 Stock Option (right to buy) 6,260 $37.6 $235,376
Option
REEVE EMMA officer: Chief Financial Officer
 Common Stock 4,010 $8.04 $32,240
Sale
REEVE EMMA officer: Chief Financial Officer
 Common Stock 4,010 $8.04 $32,240
Option
REEVE EMMA officer: Chief Financial Officer
 Stock Option (right to buy) 4,010 $8.04 $32,240
Option
REEVE EMMA officer: Chief Financial Officer
 Common Stock 1,100 $37.59 $41,344
Sale
REEVE EMMA officer: Chief Financial Officer
 Common Stock 1,100 $37.59 $41,344
CNST insider trading transactions

Constellation Pharmaceuticals
Patents

Patent
Application
Filling date: 23 Jul 2020 Issue date: 18 Aug 2022
Application
Filling date: 23 Jul 2020 Issue date: 11 Aug 2022
Application
Filling date: 26 Feb 2020 Issue date: 5 May 2022
Application
Filling date: 6 Jan 2022 Issue date: 28 Apr 2022
Application
Filling date: 27 Apr 2021 Issue date: 17 Mar 2022
Grant
Filling date: 23 Apr 2020 Issue date: 15 Mar 2022
Grant
Filling date: 15 Feb 2019 Issue date: 15 Mar 2022
Grant
Filling date: 21 Nov 2018 Issue date: 15 Feb 2022
Application
Filling date: 6 Dec 2019 Issue date: 20 Jan 2022
Grant
Filling date: 28 May 2020 Issue date: 9 Nov 2021
CNST patents

Constellation Pharmaceuticals
Earnings Call Transcripts

Quarter Transcript
Q1 2021 10 May 2021 Q1 2021 Earnings Call Transcript
Q4 2020 24 Feb 2021 Q4 2020 Earnings Call Transcript
Q2 2020 9 Aug 2020 Q2 2020 Earnings Call Transcript
Q1 2020 10 May 2020 Q1 2020 Earnings Call Transcript
CNST earnings call transcripts

Frequently Asked Questions (FAQ)

  • What's the price of Constellation Pharmaceuticals stock today?

    One share of Constellation Pharmaceuticals stock can currently be purchased for approximately $33.99.

  • When is Constellation Pharmaceuticals's next earnings date?

    Unfortunately, Constellation Pharmaceuticals's (CNST) next earnings date is currently unknown.

  • Does Constellation Pharmaceuticals pay dividends?

    No, Constellation Pharmaceuticals does not pay dividends.

  • What is Constellation Pharmaceuticals's stock symbol?

    Constellation Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "CNST".

  • What is Constellation Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Constellation Pharmaceuticals?

    Shares of Constellation Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Constellation Pharmaceuticals have?

    As Jul 2024, Constellation Pharmaceuticals employs 154 workers.

  • When Constellation Pharmaceuticals went public?

    Constellation Pharmaceuticals, Inc. is publicly traded company for more then 7 years since IPO on 19 Jul 2018.

  • What is Constellation Pharmaceuticals's official website?

    The official website for Constellation Pharmaceuticals is constellationpharma.com.

  • Where are Constellation Pharmaceuticals's headquarters?

    Constellation Pharmaceuticals is headquartered at 215 1st St Ste 200, Cambridge, MASSACHUSETTS.

  • How can i contact Constellation Pharmaceuticals?

    Constellation Pharmaceuticals's mailing address is 215 1st St Ste 200, Cambridge, MASSACHUSETTS and company can be reached via phone at +1 617 714 0555.

Constellation Pharmaceuticals company profile:

Constellation Pharmaceuticals, Inc.

constellationpharma.com
Exchange:

NASDAQ

Full time employees:

154

Industry:

Biotechnology

Sector:

Healthcare

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Its lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. The company is also developing CPI-0209 that is in Phase I dose escalation portion of a Phase I/II clinical trial to treat solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

+1 617 714 0555
215 1st St Ste 200
Cambridge, MASSACHUSETTS 02142

CIK: 0001434418
ISIN: US2103731061
CUSIP: 210373106